Euforia-induced acute hepatitis in a patient with scleroderma

BMJ Case Reports

Volumn , Issue , 2012, Pages

  Jiménez Encarnación, Esther ^a   Ríos, Grissel ^a   Muñoz Mirabal, Angel ^b   Vilá, Luis M ^a  

^a UNIVERSITY OF PUERTO RICO SCHOOL OF MEDICINE   (Puerto Rico)

^b UNIVERSITY OF PUERTO RICO   (Puerto Rico)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOTRANSFERASE; BILIRUBIN; EUFORIA; HERBACEOUS AGENT; LEVOTHYROXINE; NIFEDIPINE; UNCLASSIFIED DRUG;

ABDOMINAL TENDERNESS; ACUTE HEPATITIS; ADULT; AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; BILIRUBIN BLOOD LEVEL; CASE REPORT; CELL INFILTRATION; COMPUTER ASSISTED TOMOGRAPHY; DRUG WITHDRAWAL; FEMALE; FEVER; HEPATOMEGALY; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; HYPERBILIRUBINEMIA; HYPOALBUMINEMIA; HYPOTHYROIDISM; JAUNDICE; LIVER BIOPSY; LIVER NECROSIS; PERIPHERAL EDEMA; PHYSICAL EXAMINATION; PLASMA CELL; PRIORITY JOURNAL; SCLERODERMA; SKIN INDURATION; SYSTEMIC SCLEROSIS;

EID: 84872691831     PISSN: None     EISSN: 1757790X     Source Type: Journal    
DOI: 10.1136/bcr-2012-006907     Document Type: Article

References (24)

1. Blumenthal M, Lindstrom A, Lynch ME, et al. Herb sales continue growth-up 3.3% in 2010. HerbalGram 2011;90:64-7.
2. Boullata JI, Nace AM. Safety issues with herbal medicine. Pharmacotherapy 2000;20:257-69. (Pubitemid 30140744)
3. Stedman C. Herbal hepatotoxicity. Semin Liver Dis 2002;22:195-206. (Pubitemid 34496472)
4. Danan G, Benichou C. Causality assessment of adverse reactions to drugs-I. A novel method based on the conclusions of international consensus meetings: application to drug-induced liver injuries. J Clin Epidemiol 1993;46:1323-30. (Pubitemid 23333873)
5. Mazzanti G, Menniti-Ippolito F, Moro P, et al. Hepatotoxicity from green tea: a review of the literature and two unpublished cases. Eur J Clin Pharmacol 2009;65:331-41.
6. Ha Na Y, Dong JK, Young MK, et al. Aloe-induced toxic hepatitis. J Korean Med Sci 2010;25:492-5.
7. Stadlbauer V, Fickert P, Lackner C, et al. Hepatotoxicity of NONI juice: report of two cases. World J Gastroenterol 2005;11:4758-60. (Pubitemid 41179538)
8. Franco M, Monmany J, Domingo P, et al. Autoimmune hepatitis triggered by consumption of Goji berries. Med Clin (Barc) 2012;139:320-1.
9. Chae HB. Clinical features and diagnosis of drug induced liver injury. Korean J Hepatol 2004;10(Suppl 1):7-18.
10. Kang DY. Pathologic features of toxic and drug induced liver injury. Korean J Hepatol 2004;10(Suppl 1):19-29.
11. Lee EG, Kwon SH, Kim SH, et al. A case of hypersensitivity associated with oral aloe agent. J Asthma Allergy Clin Immunol 2003;23:833-6.
12. Bruneton J. Pharmacognosy, phytochemistry, medicinal plants, 2nd edn. Paris: Lavoisier, 1999.
13. Galati G, Lin A, Sultan AM, et al. Cellular and in vivo hepatotoxicity caused by green tea phenolic acids and catechins. Free Radic Biol Med 2006;40:570-80. (Pubitemid 43170808)
14. Bironaite D, Ollinger K. The hepatotoxicity of rhein involves impairment of mitochondrial functions. Chem Biol Interact 1997;103:35-50. (Pubitemid 27062924)
15. Foti RS, Pearson JT, Rock DA, et al. In vitro inhibition of multiple cytochrome P450 isoforms by xanthone derivatives from mangosteen extract. Drug Metab Dispos 2009;37:1848-55.
16. Zhao HL, Song CH, Chai OH. Negative effects of curcumin on liver injury induced by alcohol. Phytother Res 2012;26:1857-63.
17. Nagata M, Hidaka M, Sekiya H, et al. Effects of pomegranate juice on human cytochrome P450 2C9 and tolbutamide pharmacokinetics in rats. Drug Metab Dispos 2007;35:302-5. (Pubitemid 46148744)
18. Schlenker C, Halterman T, Kowdley KV. Rheumatologic disease and the liver. Clin Liver Dis 2011;15:153-64.
19. D'Angelo WA, Fries JF, Masi AT, et al. Pathologic observations in systemic sclerosis (scleroderma): a study of fifty-eight autopsy cases and fifty-eight matched controls. Am J Med 1969;46:428-40.
20. Hennes EM, Zeniya M, Czaja AJ, et al. International Autoimmune Hepatitis Group. Simplified criteria for the diagnosis of autoimmune hepatitis. Hepatology 2008;48:169-76. (Pubitemid 351975541)
21. Hamaguchi Y. Autoantibody profiles in systemic sclerosis: predictive value for clinical evaluation and prognosis. J Dermatol 2010;37:42-53.
22. Usha, Gupta V, Singh RG, et al. Immunological alterations in scleroderma. J Indian Acad Clin Med 2001;2:185-8.
23. Rodrigues CE, Borges CL, de Carvalho JF. Diffuse systemic sclerosis and autoimmune hepatitis: a unique association. Clin Rheumatol 2010;29:799-801.
24. Aithal GP, Watkins PB, Andrade RJ, et al. Case definition and phenotype standardization in drug-induced liver injury. Clin Pharmacol Ther 2011;89:806-15.